Scott Hensley

Scott Hensley appears in the following:

The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID

Wednesday, September 22, 2021

A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.


An FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters

Friday, September 17, 2021

Advisers to the Food and Drug Administration supported boosters of the Pfizer-BioNTech COVID-19 vaccine for a smaller group of people after they voted against recommending it for anyone 16 and older.


A Pfizer Analysis Makes The Case For A COVID Vaccine Booster

Wednesday, September 15, 2021

Pfizer says data supports its request for Food and Drug Administration approval of a third dose of the COVID-19 vaccine about six months after the second dose in people 16 years and older.


Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA

Monday, August 23, 2021

The approval replaces the emergency use authorizations granted last December and could make it easier for employers, the military and universities to mandate vaccination.


The FDA Has Approved A New Alzheimer's Drug — Here's Why That's Controversial

Monday, June 07, 2021

This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease.


Latest AstraZeneca Report Supports Effectiveness Of COVID Vaccine

Wednesday, March 24, 2021

Updated study results say the vaccine is 76% effective against symptomatic COVID-19 and 100% effective against severe disease. Independent monitors had been concerned about a previous report.


FDA Authorizes Johnson & Johnson's One-Shot COVID-19 Vaccine

Saturday, February 27, 2021

The Food and Drug Administration gave Johnson & Johnson's vaccine the green light for emergency use Saturday, a day after a panel of advisers to the agency endorsed it in a unanimous vote.


Panel Recommends FDA Authorize Johnson & Johnson Vaccine For Emergency Use

Friday, February 26, 2021

The Food and Drug Administration typically follows the advice of its expert advisers. A quick agency decision on the Johnson & Johnson vaccine is expected given the state of the pandemic.


FDA Analysis Of Johnson & Johnson COVID-19 Vaccine Finds It Safe, Effective

Wednesday, February 24, 2021

The Food and Drug Administration released an analysis of Johnson & Johnson's COVID-19 vaccine Wednesday morning that appears to support its authorization for emergency use.


Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

Friday, January 29, 2021

The vaccine did better at preventing disease in the U.S. – 72% — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.


Novavax COVID-19 Vaccine Effective, But Less So Against Variant In South Africa

Thursday, January 28, 2021

Novavax says its COVID-19 vaccine is 89% effective at preventing illness, according to an interim analysis of a U.K. study. But the vaccine wasn't as effective against some viral variants.


What's Ahead For The COVID-19 Vaccine Rollout?

Friday, January 22, 2021

As the rollout of COVID-19 vaccines unfolds in the U.S., numerous questions around distribution, supply, hesitancy and efficacy persist. Experts from Harvard and the CDC tackle these questions.


FDA Panel Recommends Moderna's COVID-19 Vaccine For Emergency Use

Thursday, December 17, 2020

Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.


FDA Analysis Of Moderna COVID-19 Vaccine Finds It Effective And Safe

Tuesday, December 15, 2020

Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.


FDA Panel Recommends COVID-19 Vaccine For Emergency Use

Thursday, December 10, 2020

In a 17-4 vote, an expert committee concluded that the scientific evidence supports the authorization of the COVID-19 vaccine from Pfizer and BioNTech for emergency use during the pandemic.


FDA Analysis Of Pfizer COVID-19 Vaccine Finds It Effective And Safe

Tuesday, December 08, 2020

The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.


Forum: Race For The COVID-19 Vaccine

Friday, November 20, 2020

Watch an expert panel discussion on the effort to develop and deploy safe and effective vaccines against COVID-19 on Friday, Nov. 20, to be live-streamed here at 12 p.m. ET


Facebook, Twitter Take Action After Trump Falsely Claims Flu Deadlier Than COVID-19

Tuesday, October 06, 2020

The president, who is being treated for COVID-19, has been downplaying the severity of the disease. He said falsely that, compared with the flu, COVID-19 is "in most populations far less lethal."


Staying At Walter Reed Hospital, Trump Has Started Remdesivir Therapy

Friday, October 02, 2020

The president, who tested positive for the coronavirus, "has completed his first dose and is resting comfortably," physician Sean Conley said in a statement.


FACT CHECK: Trump Says 50,000 Could Die From Flu. So Far, It's Half That

Monday, March 23, 2020

The president says 50,000 could die from the flu. So far, the Centers for Disease Control and Prevention says, it's 23,000 this season. Regardless, the flu can't really be compared to the coronavirus.